drugset
drugset / Trial / NCT06749639

Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy

NCT06749639 ↗

Phase 0 Recruiting 10 enrolled Peking Union Medical College Hospital
Non-randomizedSequentialOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of PUMCH-E101 injection in subjects with RDH12 retinopathy.

Timeline

Start
2024-09-20
Primary completion
2027-12-31
Completion
2030-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject PUMCH-E101 Unknown — Intravitreal

Indications

inherited retinal dystrophy